# Enanta Pharmaceuticals Inc: filings

ENTA · Nasdaq · CIK 1177648 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/enta.md) · [Financials](/companies/enta/financials.md) · [Filings](/companies/enta/filings.md) · [Insiders](/companies/enta/insiders.md)

## Reports and events: 195 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 436, 8-K 114, SC 13G/A 48, 10-Q 41, 3 29, SC 13G 27, S-8 14, 10-K 13, DEF 14A 13, DEFA14A 10, UPLOAD 10, CORRESP 9, SCHEDULE 13G/A 9, 4/A 8, S-1/A 5, SCHEDULE 13G 5, 144 4, 424B5 4, ARS 4, CT ORDER 4, 8-K/A 3, EFFECT 3, 3/A 2, S-3 2, SC 13D/A 2, 10-K/A 1, 424B4 1, 8-A12B 1, CERTNAS 1, DEFR14A 1, NT 10-Q 1, POSASR 1, S-1 1, S-3ASR 1, SC 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:05 ET | [8-K](/filings/0001193125-26-437774.md) | 8.01 Other events | 0001193125-26-437774 |
| 2026-10-28 | 07:14 ET | [8-K](/filings/0001193125-26-435092.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-435092 |
| 2026-08-12 | 07:00 ET | [10-Q](/filings/0001193125-26-345719.md) | Quarterly report, period 2026-06-30 | 0001193125-26-345719 |
| 2026-08-10 | 16:05 ET | [8-K](/filings/0001193125-26-342336.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342336 |
| 2026-07-02 | 16:56 ET | [8-K](/filings/0001193125-26-294837.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-294837 |
| 2026-06-23 | 17:28 ET | [8-K](/filings/0001193125-26-279803.md) | 8.01 Other events | 0001193125-26-279803 |
| 2026-06-18 | 07:12 ET | [8-K](/filings/0001193125-26-274950.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-274950 |
| 2026-05-13 | 07:00 ET | [10-Q](/filings/0001193125-26-220572.md) | Quarterly report, period 2026-03-31 | 0001193125-26-220572 |
| 2026-05-11 | 16:05 ET | [8-K](/filings/0001193125-26-216735.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216735 |
| 2026-03-26 | 08:00 ET | [8-K](/filings/0001193125-26-125113.md) | 8.01 Other events | 0001193125-26-125113 |
| 2026-03-12 | 16:05 ET | [8-K](/filings/0001193125-26-104109.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-104109 |
| 2026-02-11 | 16:00 ET | [10-Q](/filings/0001193125-26-046502.md) | Quarterly report, period 2025-12-31 | 0001193125-26-046502 |
| 2026-02-09 | 16:15 ET | [8-K](/filings/0001193125-26-042812.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-042812 |
| 2026-01-26 | 16:05 ET | [DEF 14A](/filings/0001193125-26-022558.md) | Proxy statement, period 2026-03-11 | 0001193125-26-022558 |
| 2025-11-19 | 16:16 ET | [10-K](/filings/0001193125-25-288121.md) | Annual report, period 2025-09-30 | 0001193125-25-288121 |
| 2025-11-17 | 16:15 ET | [8-K](/filings/0001193125-25-284633.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-284633 |
| 2025-10-01 | 16:30 ET | [8-K](/filings/0001193125-25-226828.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-226828 |
| 2025-09-29 | 08:20 ET | [8-K](/filings/0001193125-25-221791.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-221791 |
| 2025-09-29 | 06:51 ET | [8-K](/filings/0001193125-25-221527.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-221527 |
| 2025-08-27 | 16:05 ET | [8-K](/filings/0001193125-25-189691.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-189691 |
| 2025-08-20 | 07:15 ET | [8-K](/filings/0001193125-25-183719.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-183719 |
| 2025-08-13 | 16:00 ET | [10-Q](/filings/0001193125-25-179795.md) | Quarterly report, period 2025-06-30 | 0001193125-25-179795 |
| 2025-08-11 | 16:15 ET | [8-K](/filings/0001193125-25-177941.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-177941 |
| 2025-05-14 | 16:00 ET | [10-Q](/filings/0000950170-25-071340.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071340 |
| 2025-05-12 | 16:05 ET | [8-K](/filings/0000950170-25-069155.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069155 |
| 2025-03-17 | 16:05 ET | [8-K](/filings/0000950170-25-040230.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-040230 |
| 2025-02-14 | 17:05 ET | [SCHEDULE 13D/A](/filings/0000950170-25-021421.md) | Ownership report, active investor, amended | 0000950170-25-021421 |
| 2025-02-12 | 16:00 ET | [10-Q](/filings/0000950170-25-018810.md) | Quarterly report, period 2024-12-31 | 0000950170-25-018810 |
| 2025-02-10 | 16:05 ET | [8-K](/filings/0000950170-25-017035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-017035 |
| 2025-01-27 | 16:00 ET | [DEF 14A](/filings/0000950170-25-009168.md) | Proxy statement, period 2025-03-13 | 0000950170-25-009168 |
| 2024-12-09 | 08:29 ET | [8-K](/filings/0001193125-24-272936.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-272936 |
| 2024-11-27 | 08:35 ET | [10-K](/filings/0000950170-24-131260.md) | Annual report, period 2024-09-30 | 0000950170-24-131260 |
| 2024-11-25 | 16:05 ET | [8-K](/filings/0000950170-24-130553.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-130553 |
| 2024-08-07 | 16:00 ET | [10-Q](/filings/0000950170-24-092714.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092714 |
| 2024-08-05 | 16:05 ET | [8-K](/filings/0000950170-24-090722.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-090722 |
| 2024-05-08 | 16:00 ET | [10-Q](/filings/0000950170-24-055581.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055581 |
| 2024-05-06 | 16:05 ET | [8-K](/filings/0000950170-24-053532.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053532 |
| 2024-03-12 | 16:00 ET | [8-K](/filings/0000950170-24-029889.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-029889 |
| 2024-02-08 | 16:24 ET | [10-Q](/filings/0000950170-24-012796.md) | Quarterly report, period 2023-12-31 | 0000950170-24-012796 |
| 2024-02-07 | 16:05 ET | [8-K](/filings/0000950170-24-012186.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-012186 |
| 2024-01-26 | 16:25 ET | [DEF 14A](/filings/0000950170-24-007956.md) | Proxy statement, period 2024-03-06 | 0000950170-24-007956 |
| 2023-12-26 | 16:06 ET | [8-K](/filings/0001193125-23-303014.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-303014 |
| 2023-11-22 | 16:21 ET | [10-K](/filings/0000950170-23-065884.md) | Annual report, period 2023-09-30 | 0000950170-23-065884 |
| 2023-11-20 | 16:05 ET | [8-K](/filings/0000950170-23-065087.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-065087 |
| 2023-08-08 | 16:01 ET | [10-Q](/filings/0000950170-23-039754.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039754 |
| 2023-08-07 | 16:06 ET | [8-K](/filings/0000950170-23-039051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039051 |
| 2023-06-07 | 07:01 ET | [8-K](/filings/0000950170-23-026739.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-026739 |
| 2023-05-09 | 17:07 ET | [10-Q](/filings/0000950170-23-019842.md) | Quarterly report, period 2023-03-31 | 0000950170-23-019842 |
| 2023-05-08 | 16:06 ET | [8-K](/filings/0000950170-23-018788.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-018788 |
| 2023-04-27 | 16:43 ET | [8-K](/filings/0001193125-23-122434.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-122434 |

Page 1 of 4. [Older](/companies/enta/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:06 ET. No prices; not investment advice.